Ambit Biosciences Corporation (NASDAQ:
AMBI) priced its IPO of 8,125,000 shares at $8.00 per share, in-line with the expected price. Ambit has granted the underwriters a 30-day option to purchase up to an additional 1,218,750 shares at the initial public ...
[Published Street Insider - May 16 2013]